Amgen
Business
FTC Sues to Block Amgen’s $27.8 Billion Acquisition of Horizon Therapeutics
The Federal Trade Commission (FTC) filed a lawsuit on Tuesday to block Amgen's $27.8 billion acquisition of Horizon Therapeutics. The FTC alleges that the deal would harm competition in the market for autoimmune drugs.
Amgen is a leading pharmaceutical company...
Latest News
Working remotely is the future of work
In today's evolving workplace landscape, the concept of working remotely has gained significant traction and is widely believed to...